EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

PD-L1-targeted PET imaging for non-invasive assessment of immunotherapy response in lung cancer

Yang Chen, Xiufeng Liu, Yinting Hu, Ao Li, Baozhen Zeng, Peng Wang, Ganghua Tang, Benyuan Jiang, Hui Yuan, Lei Jiang

Journal for ImmunoTherapy of Cancer · 2026-04 · 14 (4) · e013837

DOI: 10.1136/jitc-2025-013837 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 01.04.2026. Verfasst von Yang Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: PET Center, Department of Nuclear Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical Universi…. Hauptthemen laut MEDLINE: Lung Neoplasms, Positron-Emission Tomography, Gallium Isotopes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Guangdong Provincial People’s Hospital, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Immune checkpoint inhibitors have improved outcomes for several malignancies; however, there remains a lack of accurate, non-invasive methods to assess tumor PD-L1 expression levels and guide immunotherapy. This study aimed to evaluate the role of PD-L1-targeted positron emission tomography (PET) imaging in predicting immunotherapy response and prognosis in lung cancer.

Methods

Four healthy volunteers and 22 treatment-naïve lung cancer patients were prospectively enrolled and underwent [ 68 Ga]Ga-PDL1p PET imaging. All patients additionally completed paired baseline [ 18 F]fluorodeoxyglucose ([ 18 F]FDG) PET scans. Of the 22 patients, 17 received ≥3 cycles of immunotherapy combined with chemotherapy and underwent follow-up [ 18 F]FDG PET or CT examinations. The correlations of baseline [ 68 Ga]Ga-PDL1p and [ 18 F]FDG uptake with tumor PD-L1 expression were evaluated. Furthermore, the associations of tumor [ 68 Ga]Ga-PDL1p uptake, [ 18 F]FDG uptake, and PD-L1 expression with immunotherapy response were analyzed, along with their predictive values for immunotherapy efficacy and outcomes.

Results

Lesions with high PD-L1 expression exhibited significantly higher [ 68 Ga]Ga-PDL1p uptake than those with low expression (p=0.007), whereas [ 18 F]FDG uptake showed no significant difference (p=0.499). At baseline, [ 68 Ga]Ga-PDL1p uptake was significantly higher in responders than in non-responders (p=0.008), with an area under the receiver operating characteristic curve of 0.886. In contrast, neither [ 18 F]FDG uptake nor PD-L1 expression levels differed significantly between the two groups. Disease progression occurred in 23.5% of patients (4/17) by the final follow-up. Patients with higher [ 68 Ga]Ga-PDL1p uptake or higher [ 18 F]FDG uptake demonstrated significantly longer progression-free survival (PFS) than those with lower uptake (p=0.033 and p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsPositron-Emission TomographyGallium IsotopesHumansB7-H1 AntigenImmune Checkpoint InhibitorsMaleFemaleAdultMiddle AgedAgedImmunochemistryPrecision Medicine

Stichwörter der Autor:innen

ImmunotherapyLung CancerfMRI / PET

Substanzen

CD274 protein, humanB7-H1 AntigenGallium IsotopesImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • PET Center, Department of Nuclear Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
  • Department of Pulmonary Surgery, Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
  • Department of Pathology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
  • Nanfang PET Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Department of Pulmonary Surgery, Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China jianglei6814@gdph.org.cn yu…
  • PET Center, Department of Nuclear Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China jianglei6814@gdph.org.cn yuanhui@gdph.org.cn jian…

Förderung

  • Guangdong Provincial People’s Hospital
  • National Key Research and Development Program of China

Zitieren

APA

Chen, Y., Liu, X., Hu, Y., Li, A., Zeng, B., Wang, P., Tang, G., Jiang, B., Yuan, H., & Jiang, L. (2026). PD-L1-targeted PET imaging for non-invasive assessment of immunotherapy response in lung cancer. Journal for ImmunoTherapy of Cancer, 14(4), e013837. https://doi.org/10.1136/jitc-2025-013837

Vancouver

Chen Y, Liu X, Hu Y, Li A, Zeng B, Wang P, et al. PD-L1-targeted PET imaging for non-invasive assessment of immunotherapy response in lung cancer. Journal for ImmunoTherapy of Cancer. 2026;14(4):e013837. doi:10.1136/jitc-2025-013837

BibTeX
@article{Chen2026,
  author = {Chen, Yang and Liu, Xiufeng and Hu, Yinting and Li, Ao and Zeng, Baozhen and Wang, Peng and Tang, Ganghua and Jiang, Benyuan and Yuan, Hui and Jiang, Lei},
  title = {PD-L1-targeted PET imaging for non-invasive assessment of immunotherapy response in lung cancer},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  volume = {14},
  number = {4},
  pages = {e013837},
  doi = {10.1136/jitc-2025-013837}
}
Kostenlos starten →